Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| STANDARD BIOTOOLS INC. | 54,025,821 | reported | 27 Aug 2024 | tx 3+1,319,562 |
| Tenaya Therapeutics, Inc. | 361,969 | reported | 03 Aug 2021 | tx 6+3,586,818−2,736,818 |
| Verve Therapeutics, Inc. | 0 | reported | 21 Jun 2021 | tx 2+620,571−5,746,183 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Aug 2024 | PURCHASE | STANDARD BIOTOOLS INC. | 250,000 | 2.19 USD | |
| 07 Aug 2024 | PURCHASE | STANDARD BIOTOOLS INC. | 500,000 | 1.57 USD | first after silence |
| 08 Aug 2024 | PURCHASE | STANDARD BIOTOOLS INC. | 569,562 | 1.64 USD | |
| 03 Aug 2021 | CONVERSION | Tenaya Therapeutics, Inc. | 2,374,849 | 0.00 USD | |
| 03 Aug 2021 | PURCHASE | Tenaya Therapeutics, Inc. | 850,000 | 15.00 USD | |
| 03 Aug 2021 | CONVERSION | Tenaya Therapeutics, Inc. | 361,969 | 0.00 USD | |
| 03 Aug 2021 | CONVERSION | Tenaya Therapeutics, Inc. | 2,012,880 | — | deriv |
| 03 Aug 2021 | CONVERSION | Tenaya Therapeutics, Inc. | 361,969 | — | deriv |
| 03 Aug 2021 | CONVERSION | Tenaya Therapeutics, Inc. | 361,969 | — | deriv |
| 21 Jun 2021 | CONVERSION | Verve Therapeutics, Inc. | 620,571 | — | |
| 21 Jun 2021 | CONVERSION | Verve Therapeutics, Inc. | 5,746,183 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 07 Aug 2024.